Delivering colonoscopy screening for low-income populations in Suffolk County: Strategies, outcomes, and benchmarks

Cancer

Volumn 119, Issue SUPPL. 15, 2013, Pages 2842-2848

  Lane, Dorothy S ^a   Messina, Catherine R ^a   Cavanagh, Mary F ^a   Anderson, Joseph C ^a,b,c  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b VA MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

cancer screening; colonoscopy; colorectal cancer; health care quality; underserved populations

Indexed keywords

ADENOMATOUS POLYP; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CECUM; CLINICAL PRACTICE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; ETHNIC DIFFERENCE; FEMALE; GASTROENTEROLOGY; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HISPANIC; HUMAN; INTESTINE PREPARATION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MINORITY GROUP; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PUBLIC-PRIVATE PARTNERSHIP; SEX DIFFERENCE; TUMOR LOCALIZATION; UNITED STATES; UNIVERSITY HOSPITAL;

CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; HEALTH CARE QUALITY; UNDERSERVED POPULATIONS;

AGED; BENCHMARKING; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK; POVERTY; TREATMENT OUTCOME;

EID: 84880528011     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28160     Document Type: Article

References (31)

1. Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2002; 52: 8-22.
2. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002; 137: 129-131.
3. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000; 342: 1766-1772.
4. Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health state-of-the-science conference statement; enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010; 152: 663-667.
5. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
6. Levin B, Lieberman DA, McFarland B, et al. American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
7. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008; 57: 253-258.
8. Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML,. Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med. 2009; 37: 1-7.
9. Imaeda A, Bender D, Fraenkel L,. What is most important to patients when deciding about colorectal cancer screening? J Gen Intern Med. 2010; 25: 688-693.
10. Lane DS, Messina CR, Cavanagh MF, Chen JJ,. A provider intervention to improve colorectal cancer screening in county health centers. Med Care. 2008; 46 (9 suppl 1): S109-S116.
11. Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW,. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med. 2009; 37: 8-16.
12. Lane DS, Cavanagh MF, Messina CR, Anderson JC,. An academic medical center model for community colorectal cancer screening: the Centers for Disease Control and Prevention demonstration program experience. Acad Med. 2010; 85: 1354-1361.
13. Cavanagh MF, Lane DS, Messina CR, Anderson JC,. Clinical case management and navigation for colonoscopy screening in an academic medical center. Cancer. 2013; 119 (suppl 15): 2894-2904.
14. Rex DK, Bond JH, Winawer S, et al. U.S. Multi-Society Task Force on Colorectal Cancer. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002; 97: 1296-1308.
15. Fletcher RH, Nadel MR, Allen JI, et al. The quality of colonoscopy services-responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med. 2010; 25: 1230-1234.
16. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD,. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008; 300: 1417-1422.
17. Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM,. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007; 99: 723-748.
18. Simon MS, Thomson CA, Pettijohn E, et al. Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1368-1378.
19. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF,. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000; 343: 169-174.
20. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006; 355: 1863-1872.
21. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007; 65: 757-766.
22. Rex DK, Petrini JL, Baron TH, et al. ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006; 101: 873-885.
23. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL,. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006; 355: 2533-2541.
24. Winawer SJ, Zauber AG, Fletcher RH, et al. US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130: 1872-1885.
25. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF,. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004; 141: 264-271.
26. Schreiner MA, Weiss DG, Lieberman DA,. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010; 139: 1497-1502.
27. Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010; 139: 1503-1510.
28. Terdiman JP, McQuaid KR,. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology. 2010; 139: 1444-1447.
29. De Jesus-Monge WE, Gonzales-Keelan C, Cruz-Correa M,. Serrated adenomas. Curr Gastroenterol Rep. 2009; 11: 420-427.
30. Nadel MR, Royalty J, Shapiro J, et al. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2834-2841.
31. Shokar NK, Carlson CA, Weller SC,. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008; 21: 414-426.